DocGo DCGO 深 沪
等待开盘 10-02 09:30:00 美东时间
0.4044
+0.005
+1.15%
华盛通- 最 高0.4133
- 今 开0.3885
- 成交量 34.55万股
- 最 低 0.3821
- 昨 收 0.3998
- 总市值 4000.66万
- 52周最高 1.65
- 市盈率 静 --
- 换手率 0.35%
- 52周最低 0.3107
- 委 比 56.25%
- 总股本 9892.84万
- 历史最高 11.41
- 量 比 0.82
- 振 幅 7.80%
- 历史最低 0.3107
- 每 手 1
- 风险率 0.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅600.93%！Ascendiant Capital上调Aytu BioPharma目标价至15美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14.5美元升至15美元；摩根大通：维持Annexon"超配"评级，目标价从14美元升至15美元
10-01 19:18
Needham Reiterates Buy on DocGo, Maintains $3 Price Target
Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.
09-30 18:02
美股大行评级 | 潜在涨幅167.3%！HC Wainwright上调Tango Therapeutics目标价至68美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Tango Therapeutics"买入"评级，目标价从66美元升至68美元；康托·菲茨杰拉德：维持Duos Technologies Group"超配"评级，目标价从26美元升至27美元
08-19 08:37
Needham Reiterates Buy on DocGo, Maintains $3 Price Target
Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.
08-18 18:13
DocGo Narrows FY2026 Sales Guidance from $300.000M-$315.000M to $305.000M-$310.000M vs $306.281M Est
DocGo (NASDAQ:DCGO) narrows FY2026 sales outlook from $300.000 million-$315.000 million to $305.000 million-$310.000 million vs $306.281 million estimate.
08-18 04:23
DocGo Q2 EPS $(0.16) Misses $(0.06) Estimate, Sales $73.425M Miss $75.404M Estimate
DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.06) by 166.67 percent. This is a 45.45 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $73.425 million which...
08-18 04:23
DocGo (DCGO) 2026年第二季度财报电话会议：收购Hicuity及调整后的展望
DocGo 2026财年第二季度营收为7340万美元，同时公司宣布了Hicuity交易，收窄了营收指引，并扩大了调整后EBITDA亏损预期。
08-17 23:41
DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
DocGo Inc. (NASDAQ:DCGO) will release its second earnings report after the closing bell on Monday, Aug. 17. Analysts expect the New York-based company to report a quarterly loss of 15 cents per share, versus a loss of 21 cents per share in the year-ago period. The consensus estimate for DocGo’s quar...
08-14 18:57
DocGo delays quarterly SEC filing briefly
DocGo ( ($DCGO) ) has released a notification of late filing. DocGo Inc. has fi...
08-10 20:25
DocGo Extends Share Repurchase Program Expiration To December 31
DocGo Extends Share Repurchase Program Expiration To December 31
07-03 04:23
